Paliperidone News
Paliperidone currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Paliperidone with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Invega is indicated for the treatment of schizophrenia in adults and in adolescents 15 years and older. Invega is indicated for the treatment of schizoaffective disorder in adults.
- Evidence level: L5
- Predicted indications (20):
- schizophrenia (100.0%)
- retinal dystrophy with or without extraocular anomalies (99.9%)
- schizophreniform disorder (99.9%)
- myopia X-linked (99.9%)
- syndromic myopia (99.9%)
- hydranencephaly (disease) (99.9%)
- congenital disorder of glycosylation with defective fucosylation (99.9%)
- myopia 26, X-linked, female-limited (99.9%)
- psychotic disorder (99.9%)
- polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (99.9%)
- Charcot-Marie-Tooth disease, demyelinating, type 1G (99.9%)
- atypical glycine encephalopathy (99.8%)
- treatment-refractory schizophrenia (99.8%)
- early-onset schizophrenia (99.8%)
- mental disorder (99.6%)
- REM sleep behavior disorder (99.5%)
- psychosexual disorder (99.4%)
- schizoaffective disorder (99.0%)
- manic bipolar affective disorder (98.9%)
- postpartum psychosis (98.9%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.